ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Establishes Women’s Health Office, Responds To Criticism

September 14, 1990

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

House Medicare Reform Bill Takes A smaller Bite In Drug Reimbursement

June 20, 1997

IOM Report Lists Cancer CER Priorities

July 3, 2009

Radiotherapy Wing Contractor Dropped

March 27, 1981

Letters: Kopans To Broder: Response Ignores Major Questions

October 15, 1993